Solutions · Medical Chart Review

Every chart, reviewed before it leaves the floor.

Adentris reviews every active chart against your full regulatory framework while the patient is still on census. Gaps, inconsistencies, and missing CDI elements surface as specific, citable findings with the rule attached.

2-min product walkthrough · Loom embed pending
Sobrius Health Resilient Recovery Treatment Simplifyance Y Combinator UC Berkeley Health Engine
73 → 96% Documentation accuracy lift, pre-submission. Customer-validated.
Built for
Acute, ambulatory, and behavioral health. Single site to multi-state network.
Hospitals & health systems Behavioral health & SUD Specialty groups Ambulatory surgery centers Multi-site networks Inpatient rehab & SNF
Why this matters now

The regulatory floor is rising in 2025-2026.

  • Active 2024-2026 DOJ payment-integrity enforcement up year over year. Documentation gaps drive False Claims Act exposure for hospital systems.
  • Active 2024-2026 MHPAEA non-quantitative treatment limitation audits. Behavioral health denials require documented parity, not boilerplate.
  • January 2026 CMS-0057-F prior-auth SLAs go live. Every PA submission needs a full electronic decision trail tied back to the chart.
  • FY 2026 HRRP penalty cap rises again. Discharge documentation completeness directly affects readmission classification and reimbursement.
The problem

Manual chart review can't keep up with the workload.

Sample-based audits miss the chart that costs the network six figures. Adentris reviews every chart, every day.
5–15 min Average human time per detailed chart review, across acute and behavioral health. HFMA, Chart Audit Benchmark Study, 2024
$262B Annual US revenue at risk from documentation and coding errors discovered after billing. Premier Inc. Trend Alert, 2024
5–10% Typical share of charts a traditional audit team can sample by hand each month. AHIMA Coding Audit Practice Brief
Curious what this would surface on your charts?
How it works

From open chart to citable finding in seconds.

Same playbook running today at Sobrius Health and Resilient Recovery Treatment.
01

Agent connects

The AI Web Agent layer logs into your EHR the way a trained reviewer would. No API project. No vendor partnership. Reads every field, form, signature block, scanned PDF, and free-text addendum.

02

Continuous review

Every active chart runs against your full rule library: payor policies, CMS guidelines, ASAM levels, Joint Commission standards, state behavioral health rules. Continuous, not retrospective.

03

Citable findings

Every gap surfaces as a specific finding with the chart reference, the missed regulatory citation, and a confidence score. No vague suggestions. Coders, clinicians, and compliance leads each see what's relevant to them.

04

Audit-ready trail

Every finding, every reviewer action, every status change is logged with timestamps and citations. Pull a complete audit trail for any chart, any time window, ready for surveyors.

90-day rollout

Predictable phases. No mystery middle.

Same playbook used at Sobrius (full production in 60 days) and Resilient Recovery, scaled to 90 days for larger networks.
Days 0–7

Scope & legal

30-min scope call. Mutual NDA and BAA back the same week. Sandbox EHR credentials issued under your governance.

  • NDA + BAA in 24 hours
  • Modules and units scoped
  • Named cohort identified
Days 8–30

Agent integration

AI Web Agent layer attached to the EHR through your sandbox. Calibration on a 50-chart cohort, with compliance team scoring outputs.

  • Sandbox EHR walk-through
  • Rule library tuned to your policies
  • 50-chart calibration cohort
Days 31–60

Active-chart coverage

Adentris runs on every active chart in scoped units. First findings hit your compliance and coding queues. Weekly review with our team.

  • 100% active-chart coverage
  • Findings routed by role
  • Weekly executive review
Days 61–90

Sign-off & scale

Audit-trail validation, team training in place, second unit (or facility) onboarding kicks off. Executive readout with quantified outcomes.

  • Audit trail validated
  • Team trained, runbooks delivered
  • Outcome readout with the CFO/CCO
What you get

Specific, measurable, customer-validated.

Numbers below are real customer outcomes from 90-day cohorts at Sobrius and Resilient Recovery. Your specifics will be quantified in the 30-day revenue check.
73 → 96% Documentation accuracy pre-submission, multi-site SUD network, 90 days.
−62% First-pass denial rate, same cohort, 90 days.
60 days From contract to full production at Sobrius Health, 100+ active patients under continuous review.
100% Of active charts continuously reviewed, vs. 5–10% with sample audit.
Worked example

A 200-bed health system reviewing roughly 12,000 active charts per month.

~720
Citable findings surfaced per month at customer-validated rates.
~$840K
Annualized revenue capture using the $640–$1,225 per-10-claims benchmark.
<3 mo
Payback against the typical Enterprise tier at this scale.
Adentris provides us real-time visibility into clinical quality and compliance and leverages modern technology to enhance client care while reducing administrative burden on our teams. This enables us to intervene earlier, support our staff more effectively and ultimately deliver better outcomes for the people we serve.
Nelson Smith, FACHE
Nelson Smith, FACHE
CEO, Sobrius Health
Want a written report quantifying what we'd find on your charts?
What findings look like

Real categories. Specific to the rule that fired.

Anonymized examples drawn from customer cohorts. Every finding cites the chart line, the rule, and the dollar exposure when applicable.
Missing co-signature
Inpatient order #4582 carries no attending co-signature 18 hours after entry. CMS COP §482.24(c)(2) on authentication.
Chart · MR# anon-7711Denial risk
Documentation gap
Daily progress note 03/14 contains no physician update for the 24-hour window. ASAM 3.5 residential continued-stay requirement.
Chart · MR# anon-2204Unfunded day risk
Coding mismatch
Pre-bill claim shows G0480 without modifier 91 for the repeat panel. NCCI edit will deny on submission.
Claim · CL-anon-8841~$310 at risk
Parity exposure
Payor denied SUD residential day on "medical necessity" with no documented NQTL parity comparison. MHPAEA exposure flagged.
Chart · MR# anon-5560Appeal eligible
Plan revision overdue
Treatment plan revision not documented in the required 7-day window. Virginia §12VAC30-130 SUD residential rule.
Chart · MR# anon-3309Audit exposure
MAT documentation
Buprenorphine continuation lacks weekly counseling note required by SAMHSA OUD treatment standards for the prior 14 days.
Chart · MR# anon-1182Compliance gap
Side by side

Adentris vs the alternatives.

Manual review samples. Other CDI tools work retrospectively and require EHR integration projects. Adentris is continuous, every chart, on any EHR, with no API project.
Capability
Adentris
Manual review
Other CDI tools
Chart coverage
100% of active charts, continuously
5–10% sample
Sampled or retrospective
When findings surface
Real time, while the patient is on census
Days to weeks after discharge
After concurrent-review queue, pre-bill at best
EHR integration
AI Web Agent, no API, any EHR, live in 60 days
Reviewer logs in manually
API or partnership, multi-month project
Behavioral health support
42 CFR Part 2 architecture, ASAM rule logic, parity-cited appeals
Variable, dependent on reviewer training
Limited or none
Audit trail
Every action timestamped, citation attached, exportable
Spreadsheet or reviewer notes
CDI-system-specific
Medical Advisory Board

Clinicians who use this. Not consultants.

Practicing physicians from named institutions review outputs, sign off on rules, and push back when our suggestions miss clinical reality. Full board →
Gerald Macciolli, MD, MBA, FCCM, FASA
Gerald Macciolli, MD, MBA, FCCM, FASA
Chief Medical Officer, Adentris
Ex. Chief Quality Officer, Envision Healthcare
LinkedIn →
Igor Kirzhner, MD
Igor Kirzhner, MD
VP Operations, Vituity
Vituity
LinkedIn →
Joel N.H. Stern, PhD
Joel N.H. Stern, PhD
Professor of Neurology & Molecular Medicine
Zucker School of Medicine at Hofstra/Northwell
LinkedIn →
Eli Pyatnitskiy, MD
Eli Pyatnitskiy, MD
Co-Director, Neurotech Lab
University of Texas at Austin
LinkedIn →
Chart review FAQ

Common questions.

Not here? Talk to sales →

01 What does Adentris read inside the chart?

Every active chart end to end: history & physical, daily notes, nursing notes, orders, results, assessments, treatment plans, MAR, MAT documentation, signature blocks, scanned PDFs inside encounters, free-text addenda. If a human reviewer can see it in the EHR, the AI Web Agent can read it.

02 Which EHRs does this work on?

Epic, Oracle Health (Cerner), MEDITECH, athenahealth, Veradigm, Kipu, Alleva, InterSystems. The AI Web Agent reads through the EHR's user interface, so no API project or vendor partnership is required to add a new system.

03 Is patient data ever sent to OpenAI, Anthropic, or Google?

No. All inference runs inside Microsoft Azure under a signed BAA, using Azure OpenAI Service or Adentris-owned models. Patient data is never sent to consumer LLM APIs.

04 How long does deployment take?

60 days from contract to full production at Sobrius Health, with the entire compliance team onboarded. Most customers start with one program or unit, then expand. The 30-day revenue check happens before any contract.

05 What about HIPAA, 42 CFR Part 2, and SOC 2?

BAA-ready under HIPAA. 42 CFR Part 2 architecture for substance use disorder and behavioral health programs. SOC 2 Type I and Type II attestations completed. All inference inside Microsoft Azure under a signed BAA. AES-256 at rest, TLS 1.3 in transit, US data residency.

06 How is this priced?

Free tier with 5 chart reviews per month per user. Starter at $100/month for 25 per user. Enterprise is annual, tied to provider count, with EHR integration, custom rule libraries, dedicated CSM, BAA, and SLA. The 30-day revenue check is free regardless.

See Medical Chart Review on your data.

Book a live walkthrough on a fully anonymized chart from your specialty. Or ship us 60–90 days of charts and we'll send a written report quantifying gaps, denial risk, and recoverable revenue. No commitment.